These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38754272)

  • 1. Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis.
    Mehrpooya M; Barakzehi MR; Nikoobakhsh M
    Heart Lung; 2024; 67():121-136. PubMed ID: 38754272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Thrombus Therapy With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review and Meta-Analysis.
    Saleiro C; Lopes J; De Campos D; Puga L; Costa M; Gonçalves L; Teixeira R
    J Cardiovasc Pharmacol Ther; 2021 May; 26(3):233-243. PubMed ID: 33259235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Oral Anticoagulants versus Vitamin K Antagonists for Left Ventricular Thrombus: A Meta-Analysis with Trial Sequential Analysis.
    Pasqualotto E; Gewehr DM; Ferreira ROM; Chavez MP; Silva CH; Cruz SA; Limachi-Choque J; Park A; Coutinho MSSA; Kubrusly LF
    Arq Bras Cardiol; 2024 Jun; 121(7):e20230738. PubMed ID: 39082575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis.
    Haller PM; Kazem N; Agewall S; Borghi C; Ceconi C; Dobrev D; Cerbai E; Grove EL; Kaski JC; Lewis BS; Niessner A; Rocca B; Rosano G; Savarese G; Schnabel RB; Semb AG; Sossalla S; Wassmann S; Sulzgruber P
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):444-453. PubMed ID: 38845369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review.
    Al-Abcha A; Herzallah K; Saleh Y; Mujer M; Abdelkarim O; Abdelnabi M; Almaghraby A; Abela GS
    Am J Cardiovasc Drugs; 2021 Jul; 21(4):435-441. PubMed ID: 33354748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome.
    Franco-Moreno A; Izquierdo-Martínez A; Ancos-Aracil C
    Drug Discov Ther; 2024 Sep; 18(4):213-219. PubMed ID: 39198152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
    Kajy M; Shokr M; Ramappa P
    Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of direct oral anticoagulants and vitamin K antagonists for left ventricular thrombus: Systematic review and meta-analysis.
    Kitano T; Nabeshima Y; Kataoka M; Takeuchi M
    PLoS One; 2021; 16(7):e0255280. PubMed ID: 34310654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Troisi F; Guida P; Vitulano N; Quadrini F; Di Monaco A; Patti G; Grimaldi M
    Am J Cardiol; 2024 May; 218():77-85. PubMed ID: 38458580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Oral Anticoagulants Compared with Vitamin K Antagonists for Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Fang S; Zhu BZ; Yang F; Wang Z; Xiang Q; Gong YJ
    Curr Pharm Des; 2022; 28(23):1902-1910. PubMed ID: 35400334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Xu W; Lv M; Wu S; Jiang S; Zeng Z; Fang Z; Qian J; Chen M; Chen J; Zhang J
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):363-377. PubMed ID: 34436708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study.
    Douros A; Cui Y; Platt RW; Filion KB; Sebastiani G; Renoux C
    Thromb Res; 2024 May; 237():71-78. PubMed ID: 38552497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.
    Malec K; Broniatowska E; Undas A
    Lupus; 2020 Jan; 29(1):37-44. PubMed ID: 31757182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus.
    Huang L; Tan Y; Pan Y
    ESC Heart Fail; 2022 Oct; 9(5):3519-3532. PubMed ID: 35894752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Burmeister C; Beran A; Mhanna M; Ghazaleh S; Tomcho JC; Maqsood A; Sajdeya O; Assaly R
    Am J Ther; 2021 Apr; 28(4):e411-e419. PubMed ID: 33852473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review.
    Sedhom R; Abdelmaseeh P; Megaly M; Asinger R
    Am J Med; 2020 Nov; 133(11):1266-1273.e6. PubMed ID: 32565258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants
    Trongtorsak A; Thangjui S; Kewcharoen J; Polpichai N; Yodsuwan R; Kittipibul V; Friedman HJ; Estrada AQ
    Acta Cardiol; 2021 Nov; 76(9):933-942. PubMed ID: 33393861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on Available "Real-World" Evidence: The Italian National Health System Perspective.
    Lorenzoni V; Pirri S; Turchetti G
    Clin Drug Investig; 2021 Mar; 41(3):255-267. PubMed ID: 33587284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series.
    Smetana KS; Dunne J; Parrott K; Davis GA; Collier ACS; Covell M; Smyth S
    J Thromb Thrombolysis; 2017 Nov; 44(4):519-524. PubMed ID: 28948507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis.
    Gue YX; Spinthakis N; Egred M; Gorog DA; Farag M
    Am J Cardiol; 2021 Mar; 142():147-151. PubMed ID: 33359200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.